Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
Kiniksa Pharmaceuticals International, plc
NASDAQ:KNSAHealthcare · Medical - Pharmaceuticals
-5.45%$92.24
AH$92.24+0.00%vs close
Mkt Cap$7.25B
Float39.17M
O/S78.57M
Vol
$ Vol
RVOL
Inst Own56.2%
SI9.6%
Earnings
Dilution
Financials Summary
Revenue$677.56M
Net Income$59.01M
Total Assets$763.63M
Free Cash Flow$25.41M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$9.5M
Total Equity$567.61M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in KNSA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$763.63M
Liabilities$196.03M
Accounts Receivable$15.59M
Accounts Payable$2.03M
Inventory$54.9M
PP&E (Net)$11.75M
Goodwill$0
Intangible Assets$15.25M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $677.56M | $423.24M | $270.26M | $220.18M | $38.54M | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 60.1% | 56.6% | 22.7% | 471.2% | - | - | - | - | - | - |
| Cost of Revenue | $307.41M | $60.91M | $56.52M | $22.89M | $9.1M | $3.81M | $3.28M | $286K | $28K | $22K |
| Gross Profit | $370.15M | $362.33M | $213.74M | $197.28M | $29.44M | -$3.81M | -$3.28M | -$286K | -$28K | -$22K |
| Gross Margin | 54.6% | 85.6% | 79.1% | 89.6% | 76.4% | - | - | - | - | - |
| Research and Development | $96.85M | $111.62M | $76.1M | $65.49M | $99.3M | $109.64M | $132.93M | $86.6M | $56.36M | $17.44M |
| Selling, General, and Administrative | $196.27M | $168.01M | $129.43M | $97.95M | $85.95M | $43.92M | $33.75M | $21.56M | $9.04M | $6.56M |
| Other | $0 | $128.31M | $33.41M | $24.07M | $835K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $292.93M | $407.94M | $238.93M | $187.51M | $186.08M | $153.56M | $166.68M | $108.16M | $65.4M | $24M |
| Operating Income (EBIT) | $77.22M | -$45.62M | -$25.2M | $9.77M | -$156.64M | -$157.36M | -$169.96M | -$108.16M | -$65.4M | -$24M |
| Operating Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $11.65M | $9.46M | $8.54M | $1.25M | $97K | $1.13M | $6.05M | $4.72M | $529K | $65K |
| Other Income (Expense) | $11.65M | $9.46M | $8.54M | $1.25M | $97K | $1.13M | $6.05M | $4.72M | $529K | $65K |
| Income Before Tax (EBT) | $88.87M | -$36.15M | -$16.65M | $11.03M | -$156.54M | -$156.23M | -$163.91M | -$103.44M | -$64.87M | -$23.94M |
| Income Tax Expense | $29.86M | $7.04M | -$30.74M | -$172.34M | $1.39M | $5.15M | -$2.05M | -$214K | $2K | $36K |
| Net Income | $59.01M | -$43.19M | $14.08M | $183.36M | -$157.92M | -$161.38M | -$161.87M | -$103.23M | -$64.87M | -$23.97M |
| Net Income Margin | 8.7% | -10.2% | 5.2% | 83.3% | -409.7% | - | - | - | - | - |
| Supplementary Data | ||||||||||
| EPS | 0.80 | -0.60 | 0.20 | 2.64 | -2.30 | -2.61 | -2.99 | -3.49 | -2.00 | -0.74 |
| Diluted EPS | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 | -2.61 | -2.99 | -3.49 | -2.00 | -0.74 |
| Weighted Average OS | 74.20M | 71.42M | 70.06M | 69.38M | 68.58M | 61.84M | 54.05M | 29.55M | 32.47M | 32.47M |
| EBITDA | $90.42M | -$34.46M | -$14.31M | $13.43M | -$154.18M | -$153.82M | -$161.85M | -$107.87M | -$65.37M | -$23.98M |
| EBITDA Margin | 13.3% | -8.1% | -5.3% | 6.1% | -400.0% | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $165.6M | $183.58M | $107.95M | $122.72M | $122.47M | $114.04M | $46.93M | $307.3M | $45.55M | $55.97M |
| Short-Term Investments | $248.48M | $60.05M | $98.42M | $67.89M | $59.73M | $209.44M | $186.45M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $414.07M | $243.63M | $206.37M | $190.61M | $182.2M | $323.48M | $233.38M | $307.3M | $45.55M | $55.97M |
| Accounts Receivable | $15.59M | $41.72M | $21.27M | $20.32M | $3.98M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $54.9M | $26.36M | $31.12M | $21.6M | $3.67M | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $42.61M | $20.08M | $17.54M | $10.54M | $0 | $210K | $0 | $6.45M | $105K | $105K |
| Total Current Assets | $527.18M | $331.8M | $276.3M | $243.06M | $196.45M | $333.25M | $241.63M | $313.75M | $47.1M | $56.33M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $11.75M | $11.04M | $12.66M | $7.04M | $8.38M | $10.62M | $8.32M | $6.36M | $125K | $84K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $15.25M | $16.25M | $17.25M | $18.25M | $19.25M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $210K | $0 | $0 |
| Deferred Tax Assets | $198.15M | $211.15M | $219.28M | $185.5M | $0 | $10K | $4.37M | $1.22M | $238K | $41K |
| Other Long-Term Assets | $11.31M | $10.31M | $827K | $5.82M | $8.72M | $5.59M | $210K | $643K | $25K | $8K |
| Total Long-Term Assets | $236.46M | $248.75M | $250.03M | $216.61M | $36.35M | $16.21M | $12.91M | $8.21M | $388K | $133K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $763.63M | $580.55M | $526.32M | $459.67M | $232.8M | $349.46M | $254.53M | $321.96M | $47.49M | $56.47M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $2.03M | $2.04M | $8.25M | $7.9M | $1.87M | $503K | $5.69M | $10.92M | $1.22M | $212K |
| Short-Term Debt | $2.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $31.81M | $0 | $307K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $102.36M | $33.12M | $36.91M | $16.97M | $1.54M | $7.74M | $7.11M | $25.96M | $14.64M | $1.1M |
| Total Current Liabilities | $139.18M | $100.62M | $63.67M | $47.07M | $44.82M | $31.85M | $27.83M | $42.55M | $17.43M | $2.3M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $31.81M | $31.81M | $11.95M | $12M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.22M | $0 | $0 |
| Other Long-Term Liabilities | $18.52M | $1.82M | $1.86M | $1.84M | $270K | $805K | $326K | $144K | $119.77M | $79.9M |
| Total Long-Term Liabilities | $56.84M | $41.5M | $23.82M | $16.46M | $2.94M | $5.68M | $1.28M | $144K | $119.77M | $79.9M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $196.03M | $142.12M | $87.48M | $63.52M | $47.76M | $37.53M | $29.11M | $42.7M | $137.2M | $82.2M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $119.77M | $79.9M |
| Common Stock | $21K | $20K | $20K | $19K | $18K | $18K | $15K | $13K | $1K | $1K |
| Retained Earnings | -$462.14M | -$521.14M | -$477.95M | -$492.03M | -$675.4M | -$517.47M | -$356.09M | -$194.22M | -$91M | -$26.13M |
| Comprehensive Income & Other | -$25K | -$163K | $6K | $44K | -$66K | -$34K | $33K | -$4K | -$52K | -$24K |
| Other Stockholders' Equity | $1.03B | $959.56M | $916.77M | $888.16M | $860.42M | $829.39M | $581.5M | -$13K | $1.29M | $392K |
| Total Equity | $567.61M | $438.44M | $438.84M | $396.15M | $185.04M | $311.94M | $225.42M | -$194.22M | -$89.71M | -$25.73M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $763.63M | $580.55M | $526.32M | $459.67M | $232.8M | $349.46M | $254.53M | -$151.53M | $47.49M | $56.47M |
| Supplementary Data | ||||||||||
| Total Debt | $9.5M | $9.86M | $12.26M | $5.92M | $6.05M | $6.99M | $2.65M | $0 | $0 | $0 |
| Net Debt | -$156.1M | -$173.73M | -$95.7M | -$116.8M | -$116.42M | -$107.05M | -$44.28M | -$307.3M | -$45.55M | -$55.97M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$43.19M | -$43.19M | $14.08M | $183.36M | -$157.92M | -$161.38M | -$161.87M | -$103.23M | -$64.87M | -$23.97M |
| Depreciation & Amortization | $1.55M | $1.7M | $2.34M | $2.4M | $2.35M | $2.4M | $2.07M | $286K | $28K | $22K |
| Deferred Income Tax | $8.13M | $8.13M | -$33.79M | -$185.5M | $11K | $4.36M | -$3.16M | -$978K | -$197K | -$46K |
| Stock-Based Compensation | $30.69M | $30.69M | $27.15M | $25.12M | $25.17M | $20.88M | $15.08M | $5.7M | $897K | $368K |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $26.13M | -$20.46M | -$950K | -$16.33M | -$3.91M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $4.76M | $4.76M | -$9.52M | -$17.92M | -$3.67M | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$6.31M | -$6.31M | $347K | $6.03M | $1.37M | -$4.97M | -$4.71M | $8.82M | $1.01M | $119K |
| Other Working Capital | $27.05M | $46.81M | $11.48M | $5.65M | $6.91M | $654K | -$12.32M | $9.51M | $12.92M | $1.64M |
| Total Working Capital Change | $51.63M | $24.81M | $1.35M | -$22.57M | $689K | -$4.32M | -$17.02M | $18.33M | $13.93M | $1.76M |
| Other Non-Cash Items | -$23.13M | $3.55M | $2.17M | $2.99M | $3.4M | $1.52M | $6.53M | -$1.12M | -$53K | $293K |
| Net Cash from Operating | $25.69M | $25.69M | $13.3M | $5.81M | -$126.3M | -$136.53M | -$158.37M | -$81.01M | -$50.22M | -$21.87M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$277K | -$277K | -$130K | -$105K | -$415K | -$283K | -$3.2M | -$5.29M | -$69K | -$3K |
| Acquisitions | $0 | $25K | $0 | $0 | $0 | $23.16M | -$52.42M | $0 | $0 | $0 |
| Purchases of Investments | -$202.01M | -$202.01M | -$204.93M | -$135.86M | -$157.25M | -$430.21M | -$488.77M | -$402.01M | $0 | $0 |
| Sales of Investments | $239.94M | $239.94M | $175.51M | $127.8M | $306.3M | $407.05M | $541.19M | $168.1M | $0 | $0 |
| Other Investing Activities | $25K | $0 | $0 | $91K | -$20M | -$23.16M | $52.42M | -$233.91M | $0 | $0 |
| Net Cash from Investing | $37.67M | $37.67M | -$29.56M | -$8.08M | $128.63M | -$23.44M | $49.21M | -$239.2M | -$69K | -$3K |
| Financing Activities | ||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $3.42M | $5.88M | $228.22M | $83.11M | $159.19M | $39.87M | $42.51M |
| Common Stock Repurchases | -$7.73M | -$4.98M | -$2.21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $20M | $17.25M | $3.7M | -$901K | $0 | -$1.14M | $1M | -$3.28M | $0 | $10K |
| Net Cash from Financing | $12.27M | $12.27M | $1.5M | $2.52M | $5.88M | $227.09M | $84.11M | $346.74M | $39.87M | $42.51M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $75.63M | $75.63M | -$14.76M | $245K | $8.22M | $67.11M | -$25.05M | $26.53M | -$10.41M | $20.64M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | $25.69M | $25.69M | $13.3M | $5.81M | -$126.3M | -$136.53M | -$158.37M | -$81.01M | -$50.22M | -$21.87M |
| Capital Expenditure | -$277K | -$277K | -$130K | -$105K | -$20.41M | -$283K | -$3.2M | -$5.29M | -$69K | -$3K |
| Free Cash Flow | $25.41M | $25.41M | $13.17M | $5.7M | -$146.71M | -$136.81M | -$161.57M | -$86.3M | -$50.29M | -$21.87M |
| Cash at Beginning | $107.95M | $107.95M | $122.72M | $122.47M | $114.25M | $47.14M | $72.19M | $45.66M | $56.08M | $35.44M |
| Cash at End | $183.58M | $183.58M | $107.95M | $122.72M | $122.47M | $114.25M | $47.14M | $72.19M | $45.66M | $56.08M |